Researchers from Utrecht University said on Thursday they are in talks with major pharmaceutical manufacturers on developing an antibody treatment for the new coronavirus.
The National Institutes of Health (NIH) said on Thursday it began a study to evaluate the combination of antibiotic azithromycin and malaria drug hydroxychloroquine, which was previously touted by U.S. President Donald Trump as a "game changer", for the treatment of COVID-19.
France's cumulative coronavirus death toll edged back above Spain's as the health ministry reported that the number of people who died of COVID-19 in the past 24 hours increased by 351 or 1.3% to 27,425.
A powerful Venezuelan official is seeking an investigation of the nation's academy of scientists for publishing research that questioned official figures on coronavirus cases and estimated the pandemic may hit the country hard in the coming months.
A closely watched coronavirus vaccine being developed by scientists at Oxford University appears protective in a small study of six monkeys, promising findings that led to the start of human trials late last month, U.S. and British researchers reported on Thursday.
Britain is in talks with Swiss drugmaker Roche Holding AG to buy an accurate COVID-19 antibody test, following the lead of the European Union and United States which have already given preliminary approval to the tests.
Britain's coronavirus test-and-trace app has been downloaded by 72,300 residents of the Isle of Wight, where it is being trialled, Transport Secretary Grant Shapps said on Thursday.
France's cumulative coronavirus death toll edged over Spain's again as France reported on Thursday the number of people who died of COVID-19 in the past 24 hours increased by 351 or 1.3% to 27,425.
Sanofi chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying some countries would get priority access.
Japan has begun treating severely ill COVID-19 patients with Gilead Sciences Inc's coronavirus drug remdesivir, days after granting emergency approval to the medication the company is supplying as part of its pledged donation.